Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Continuous treatment with calcitonin (CT) to inhibit osteoclastic bone resorption results in acquired resistance. The mechanisms of this “escape” phenomenon are not yet established. The aim of this study was to examine the effects of continuous treatment with CT on the generation of osteoclasts and calcitonin receptor (CTR) expression in mouse bone marrow cultures. This was done by daily CT treatment of mouse bone marrow cultures from day 0, when only undifferentiated mononuclear precursors of osteoclast-like cells were present, or commencing from day 6, when differentiated osteoclast-like cells were abundant. The response to CT treatment was determined by quantitation of cells positive for tartrate-resistant acid phosphatase (TRAP) and binding of 125I-salmon CT. Calcitonin receptor and TRAP mRNA levels were determined using semi-quantitative reverse transcription/polymerase chain reaction. When cultures were treated with CT from day 0, TRAP-positive multinucleated cells appeared. These cells expressed only very low levels of CTR or CTR mRNA and were morphologically indistinguishable from osteoclast-like cells formed in control cultures. They also displayed the ability to resorb bone. Continuous CT treatment of cultures from day 6 rapidly reduced the CTR mRNA levels, with a t1/2 of 6 to 12 h, and these levels remained low thereafter. 125I-salmon CT binding capacity, as determined by autoradiography, was lost in parallel. These effects were specific for the CTR since there was no consistent effect on TRAP mRNA levels. Based on these data, we suggest that the “escape” phenomenon may result from a prolonged CT-induced loss of CT responsiveness due, at least in part, both to reduced synthesis of CTR, and to the appearance in bone of CTR-deficient osteoclasts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, an earlier study of murine bone marrow cultures treated with 1,25(OH) 2 D 3 found that the presence of sCT had no effect on the number of mononucleated and multinucleated TRAP-positive cells (106).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [106]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Tso, J. Y., Sun, X.-H., Kao, T.-H., Reece, K. S., & Wu, R. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.7.2485 · Cited by 1,791
TAKAHASHI, N., YAMANA, H., YOSHIKI, S., ROODMAN, G. D., MUNDY, G. R., JONES, S. J., BOYDE, A., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 730
Cells of bone: proliferation, differentiation, and hormonal regulation
Nijweide, P. J., Burger, E. H., & Feyen, J. H. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.855 · Cited by 474
Holtrop, M. E., Raisz, L. G., & Simmons, H. A. (1974) · The Journal of Cell Biology · doi:10.1083/jcb.60.2.346 · Cited by 342
Roodman, G. D., Ibbotson, K. J., MacDonald, B. R., Kuehl, T. J., & Mundy, G. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8213 · Cited by 280
Warshawsky, H., Goltzman, D., Rouleau, M. F., & Bergeron, J. J. (1980) · The Journal of cell biology · doi:10.1083/jcb.85.3.682 · Cited by 210
MACDONALD, B. R., TAKAHASHI, N., MCMANUS, L. M., HOLAHAN, MUNDY, G. R., & ROODMAN, G. D. (1987) · Endocrinology · doi:10.1210/endo-120-6-2326 · Cited by 162
Preparation and characterization of a mouse osteoclast-like multinucleated cell population
Akatsu, T., Tamura, T., Takahashi, N., Udagawa, N., Tanaka, S., Sasaki, T., Yamaguchi, A., Nagata, N., & Dr. Suda, T. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071109 · Cited by 155
WENER, J. A., GORTON, S. J., & RAISŹ, L. G. (1972) · Endocrinology · doi:10.1210/endo-90-3-752 · Cited by 152
Cited by
Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
Cornish, J., Callon, K. E., Bava, U., Kamona, S. A., Cooper, G. J. S., & Reid, I. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00494-x · Cited by 173
Dr. Quinn, J. M. W., Horwood, N. J., Elliott, J., Gillespie, M. T., & Martin, T. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1459 · Cited by 141
Self-citationThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Luchin, A., Purdom, G., Murphy, K., Clark, M.-Y., Angel, N., Cassady, A. I., Hume, D. A., & Ostrowski, M. C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.451 · Cited by 126
Calcitonin Therapy in Osteoporosis
Muñoz‐Torres, M., Alonso, G., & Raya, P. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00006 · Cited by 111
Masi, L., Becherini, L., Colli, E., Gennari, L., Mansani, R., Falchetti, A., Becorpi, A. M., Cepollaro, C., Gonnelli, S., Tanini, A., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8880 · Cited by 102
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Biomineralisation markers during a phase of active growth in Pinctada margaritifera
Rousseau, M., Plouguerné, E., Wan, G., Wan, R., Lopez, É., & Fouchereau‐Péron, M. (2003) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(03)00070-9 · Cited by 59
Masi, L., Becherini, L., Gennari, L., Colli, E., Mansani, R., Falchetti, A., Cepollaro, C., Gonnelli, S., Tanini, A., & Brandi, M. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8445 · Cited by 57
Anderson, P., O’Loughlin, P. D., May, B. K., & Morris, H. A. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.089 · Cited by 53
Inoue, D., Shih, C., Galson, D. L., Goldring, S. R., Horne, W. C., & Baron, R. (1999) · Endocrinology · doi:10.1210/endo.140.3.6551 · Cited by 40
G Protein and Its signaling pathway in bone development and disease
Wu, M., Deng, L., Zhu, G., & Li, Y.-P. (2010) · Frontiers in bioscience · doi:10.2741/3656 · Cited by 42
Ikegame, M., Ejiri, S., & Ozawa, H. (2004) · Bone · doi:10.1016/j.bone.2004.03.018 · Cited by 32
Self-citationNotoya, M., Arai, R., Katafuchi, T., Minamino, N., & Hagiwara, H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.034 · Cited by 25
Katayama, T., Furuya, M., Yamaichi, K., Konishi, K., Sugiura, N., Murafuji, H., Magota, K., Saito, M., Tanaka, S., & Oikawa, S. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00125-8 · Cited by 23
Wada-Mihara, C., Seto, H., Ohba, H., Tokunaga, K., Kido, J., Nagata, T., & Naruishi, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.165 · Cited by 23
A novel calcitonin receptor gene in human osteoclasts from normal bone marrow
Nishikawa, T., Ishikawa, H., Yamamoto, S., & Koshihara, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01176-x · Cited by 23
Tsukamoto, M., Menuki, K., Murai, T., Hatakeyama, A., Takada, S., Furukawa, K., & Sakai, A. (2016) · Bone · doi:10.1016/j.bone.2016.01.025 · Cited by 19
Martin, T. J. (1999) · Bone · doi:10.1016/s8756-3282(99)00068-x · Cited by 15
Self-citationIdentification of a novel calcitonin-response element in the promoter of the human p21WAF1/CIP1 gene
Evdokiou, A., Raggatt, L. J., Sakai, T., & Findlay, D. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250195 · Cited by 18
Calcium metabolism related markers during the growth ofHaliotis tuberculata
Duvail, L., & Fouchereau‐Péron, M. (2001) · Invertebrate Reproduction & Development · doi:10.1080/07924259.2001.9652720 · Cited by 11
The Hormonal Regulation of Calcium Metabolism
Tebben, P. J., & Kumar, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00065-3 · Cited by 10
Findlay, D. M., Houssami, S., Christopoulos, G., & Sexton, P. M. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895320 · Cited by 9
Structure and Molecular Biology of the Calcitonin Receptor
Galson, D. L., & Goldring, S. R. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50136-0 · Cited by 9
The Structure and Molecular Biology of the Calcitonin Receptor
Goldring, S. R. (1998) · Advances in organ biology · doi:10.1016/s1569-2590(08)60113-5 · Cited by 8
Martin, T. J., Findlay, D. M., Moseley, J. M., & Sexton, P. M. (1998) · Elsevier eBooks · doi:10.1016/b978-012068700-8/50005-0 · Cited by 27
Self-citationParathyroid hormone analogues for treatment of osteoporosis and hypercalcaemia
Morley, P., Whitfield, J. F., & Willick, G. E. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.1.31 · Cited by 6
Cell active and functionally-relevant small-molecule agonists of calcitonin receptor
Zhao, S., Guo, S., Yang, C., Gong, Z., Wang, Y., Jia, Y., Jiang, X., Xu, L., Shi, L., Yu, X., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103596 · Cited by 3
Findlay, D. M., Sexton, P. M., & Martin, T. J. (2016) · Endocrinology: Adult and Pediatric · doi:10.1016/b978-0-323-18907-1.00058-5 · Cited by 2
Self-citationLa calcitonine et son récepteur
Frendo, J., Moukhtar, M. S., & Orcel, P. (2000) · Revue du Rhumatisme · doi:10.1016/s1169-8330(00)80077-0 · Cited by 3
Molecular biology and regulation of the calcitonin receptor
Goldring, S. R. (1997) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf02490074 · Cited by 2
The Hormonal Regulation of Calcium Metabolism
Tebben, P. J., & Kumar, R. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50069-3 · Cited by 2
Martin, T. J., Findlay, D. M., & Sexton, P. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00057-5 · Cited by 2
Self-citationADAMs, OSTEOCLASTOGENESIS AND BONE DESTRUCTION IN THE LOOSENING OF THE TOTALLY REPLACED HIP
Ma, G. (2009) · Helda - University of Helsinki Institutional Repository
Reflections on Development of Concepts of Intercellular Communication in Bone
Martin, T. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00004-2 · Cited by 1
Self-citationdi Filippo, L., Franzese, V., Incampo, G., Formenti, A. M., Albanese, L., Doga, M., Onorati, D., Maggiore, R., Rosati, R., Perticone, F., et al. (2026) · Bone · doi:10.1016/j.bone.2026.117872
Metadata
- Authors
- Ikegame, M., Rakopoulos, M., Martin, T. J., Moseley, J. M., & Dr. Findlay, D. M.
- Affiliations
- St Vincents Institute of Medical Research (AU)
- St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- ORCID
- Ikegame, Mika
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-04-01
- Volume
- 11
- Issue
- 4
- Pages
- 456-465
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2071168489
- Semantic Scholar
- 416726f64eae430743ab86393a62090d0e09a1b6
- Cited by
- 36
- References
- 35
- Citations by year
- 2026: 1 · 2020: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- calcitonin, calcitonin receptor, osteoclast-like cells, bone resorption, tartrate-resistant acid phosphatase, receptor mRNA expression, bone marrow culture, receptor down-regulation, osteoclastogenesis
- MeSH terms
- Tartrate-Resistant Acid Phosphatase, Acid Phosphatase, Animals, Base Sequence, Binding Sites, Bone Marrow, Bone Marrow Cells, Bone Resorption, Calcitonin, Cell Differentiation, Cells, Cultured, Femur, Humerus, Iodine Radioisotopes, Isoenzymes, Mice, Inbred C57BL, Microscopy, Electron, Scanning, Molecular Sequence Data, Osteoclasts, RNA, Messenger, Tibia, Giant Cells, Polymerase Chain Reaction, DNA Primers, Receptors, Calcitonin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.